Astaxanthin: miracle supplement or expensive placebo?

Astaxanthin: the antioxidant that promises to protect eyes and skin, but doesn't convince everyone

Astaxanthin, a carotenoid with antioxidant capacity 6,000 times greater than vitamin C, has gained popularity as a supplement for eye health, sun protection and muscle recovery. However, after two weeks of use, user testimonials clash with the skepticism of those who point to the placebo effect as the main explanation.

What does the evidence say about its benefits?

Its defenders point out that it is one of the few antioxidants capable of crossing the blood-retina barrier, which would give it potential against age-related macular degeneration. It is also credited with some ability to filter blue light and modulate muscle inflammation, which could explain the reduced soreness reported by some consumers. However, serious studies focus on advanced eye conditions, not on eye strain from screen use. As for the skin, it is acknowledged that it can produce a slight golden tone, but its photoprotective effect is anecdotal and does not replace conventional sunscreen.

The debate over accumulation and tanning

A recurring concern is the possible orange discoloration of the skin. Unlike beta-carotene, astaxanthin is deposited in fatty tissues with a more reddish tone, but at a dose of 12 mg per day the change is almost imperceptible, unless the dose is abused. Its fat-soluble nature means it is stored in the body, but not with the intensity of the dreaded effects seen in 1980s bodybuilders.

Placebo or reality: the muscle recovery controversy

The claim that astaxanthin reduces muscle soreness has divided opinion. While some report faster recovery after exercise, others warn that reduced inflammation could translate into reduced muscle gains in the long term. Science has not yet given a conclusive answer: the anti-inflammatory mechanisms exist, but their real magnitude in amateur athletes remains a matter of debate.

With all this, astaxanthin presents itself as a supplement with a theoretical basis but limited practical evidence. Most likely, for the average user, the effect is a mix of moderate real benefit and suggestion. Until research advances, the decision to spend 30 euros a month on these capsules will remain a matter of faith.